Tuesday, April 27, 2010

Trisakti University Event on 9 April 2010


Advantcare had a joint-event with the Medical Faculty of Trisakti University, Jakarta on the 9th of April 2010. The event was attended by about 100 doctors consisting university alumni, lecturers, practicing GPs and Specialists.


Advantcare was represented by Mr Harris Hor, Marketing Director, who presented on the company's concept of Continuous Patient Management Services Chain. This include the introduction of the 24-hour BP monitor - BPro, BPro CASP; Telemedicine - 2nd Opinion Software; the World's 1st Hybrid MRI machine ; Tele-Radiology and E-consultation.






Bpro
Device













Tele-Radiology




Pica Hybrid MRI








The audience was very excited on the low cost high quality products such as the Hybrid MRI machine and the E-consultation Software. Both has low maintenance, allows fast file transfers and excellent results under low bandwidths.
Advantcare invited 2 famous from Singapore to share with the Indonesian doctors their clinical experiences too.

















Dr Chuang Hsuan-Hung, a Cardiologist at Gleneagles Medical Centre spoke on the diagnosis and management of Cardiovascular Diseases.
  
Private practicing Medical Oncologist, Dr Wong Weng Seng, also shared his clinical experience on the management of various cancers in his practice at Paragon Medical Centre.
Dr Wong Weng Seng
with Dean of Trisakti
University, Prof dr Julius

 The session ended with a ton of questions and answers for the 2 consultant specialists as well as on the services of Advantcare.
































































Labels: , , , , , , , , , , , , , , , , ,

Tuesday, March 24, 2009

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease

Background
Coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) are alternative treatments for multivessel coronary disease. Although the procedures have been compared in several randomised trials, their long-term effects on mortality in key clinical subgroups are uncertain. We undertook a collaborative analysis of data from randomised trials to assess whether the effects of the procedures on mortality are modified by patient characteristics.
Methods
We pooled individual patient data from ten randomised trials to compare the effectiveness of CABG with PCI according to patients' baseline clinical characteristics. We used stratified, random effects Cox proportional hazards models to test the effect on all-cause mortality of randomised treatment assignment and its interaction with clinical characteristics. All analyses were by intention to treat.
Findings
Ten participating trials provided data on 7812 patients. PCI was done with balloon angioplasty in six trials and with bare-metal stents in four trials. Over a median follow-up of 5·9 years (IQR 5·0—10·0), 575 (15%) of 3889 patients assigned to CABG died compared with 628 (16%) of 3923 patients assigned to PCI (hazard ratio [HR] 0·91, 95% CI 0·82—1·02; p=0·12). In patients with diabetes (CABG, n=615; PCI, n=618), mortality was substantially lower in the CABG group than in the PCI group (HR 0·70, 0·56—0·87); however, mortality was similar between groups in patients without diabetes (HR 0·98, 0·86—1·12; p=0·014 for interaction). Patient age modified the effect of treatment on mortality, with hazard ratios of 1·25 (0·94—1·66) in patients younger than 55 years, 0·90 (0·75—1·09) in patients aged 55—64 years, and 0·82 (0·70—0·97) in patients 65 years and older (p=0·002 for interaction). Treatment effect was not modified by the number of diseased vessels or other baseline characteristics.
Interpretation
Long-term mortality is similar after CABG and PCI in most patient subgroups with multivessel coronary artery disease, so choice of treatment should depend on patient preferences for other outcomes. CABG might be a better option for patients with diabetes and patients aged 65 years or older because we found mortality to be lower in these subgroups.